Mark S. Yerby

3.3k total citations · 1 hit paper
37 papers, 1.7k citations indexed

About

Mark S. Yerby is a scholar working on Pediatrics, Perinatology and Child Health, Public Health, Environmental and Occupational Health and Psychiatry and Mental health. According to data from OpenAlex, Mark S. Yerby has authored 37 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Pediatrics, Perinatology and Child Health, 24 papers in Public Health, Environmental and Occupational Health and 18 papers in Psychiatry and Mental health. Recurrent topics in Mark S. Yerby's work include Pharmacological Effects and Toxicity Studies (32 papers), Pregnancy and Medication Impact (24 papers) and Epilepsy research and treatment (17 papers). Mark S. Yerby is often cited by papers focused on Pharmacological Effects and Toxicity Studies (32 papers), Pregnancy and Medication Impact (24 papers) and Epilepsy research and treatment (17 papers). Mark S. Yerby collaborates with scholars based in United States, Australia and United Kingdom. Mark S. Yerby's co-authors include Sonia Hernández–Dı́az, Lewis B. Holmes, W. Allen Hauser, Robert Mittendorf, C. R. Smith, Thomas D. Koepsell, Janet R. Daling, Janet D. Cragan, Orrin Devinsky and Cheng‐Mei Shaw and has published in prestigious journals such as Nature, Neurology and Annals of Neurology.

In The Last Decade

Mark S. Yerby

37 papers receiving 1.7k citations

Hit Papers

Comparative safety of antiepileptic drugs during pregnancy 2012 2026 2016 2021 2012 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark S. Yerby United States 19 1.2k 838 834 213 204 37 1.7k
Herbert Kühl Germany 20 90 0.1× 454 0.5× 72 0.1× 174 0.8× 72 0.4× 54 1.2k
Bruce A. Buehler United States 18 277 0.2× 84 0.1× 70 0.1× 281 1.3× 29 0.1× 37 786
Pernilla Svedin Sweden 17 650 0.6× 68 0.1× 25 0.0× 253 1.2× 87 0.4× 36 1.2k
Anne Kiuru Sweden 15 139 0.1× 207 0.2× 39 0.0× 362 1.7× 23 0.1× 22 915
D. Croci Italy 14 253 0.2× 65 0.1× 233 0.3× 246 1.2× 21 0.1× 24 636
Amina Barhdadi Canada 15 288 0.2× 99 0.1× 49 0.1× 402 1.9× 20 0.1× 33 1.3k
David Delano United States 8 178 0.2× 67 0.1× 34 0.0× 1.2k 5.6× 56 0.3× 9 1.8k
Penelope K. Manasco United States 14 537 0.5× 127 0.2× 534 0.6× 252 1.2× 7 0.0× 24 1.2k
Masataka Arima Japan 19 199 0.2× 84 0.1× 25 0.0× 369 1.7× 30 0.1× 85 1.0k
Klary E. Niezen‐Koning Netherlands 22 166 0.1× 44 0.1× 70 0.1× 709 3.3× 75 0.4× 59 1.8k

Countries citing papers authored by Mark S. Yerby

Since Specialization
Citations

This map shows the geographic impact of Mark S. Yerby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark S. Yerby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark S. Yerby more than expected).

Fields of papers citing papers by Mark S. Yerby

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark S. Yerby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark S. Yerby. The network helps show where Mark S. Yerby may publish in the future.

Co-authorship network of co-authors of Mark S. Yerby

This figure shows the co-authorship network connecting the top 25 collaborators of Mark S. Yerby. A scholar is included among the top collaborators of Mark S. Yerby based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark S. Yerby. Mark S. Yerby is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hernández–Dı́az, Sonia, Amy Lyons, Hyo Chae Paik, et al.. (2025). Use of Antiseizure Medications Early in Pregnancy and the Risk of Major Malformations in the Newborn. Neurology. 105(3). e213786–e213786. 1 indexed citations
2.
Holmes, Lewis B., et al.. (2023). Ascertainment of malformations in pregnancy registries: Lessons learned in the North American AED Pregnancy Registry. Birth Defects Research. 115(14). 1274–1283. 4 indexed citations
3.
Hernández–Dı́az, Sonia, Robert Mittendorf, C. R. Smith, et al.. (2013). Association Between Topiramate and Zonisamide Use During Pregnancy and Low Birth Weight. Obstetrics and Gynecology. 123(1). 21–28. 57 indexed citations
4.
Combs‐Cantrell, Deborah T. & Mark S. Yerby. (2003). Case Reports of Women with Epilepsy. Epilepsia. 44(s3). 41–44. 4 indexed citations
5.
Yerby, Mark S.. (2003). Clinical Care of Pregnant Women with Epilepsy: Neural Tube Defects and Folic Acid Supplementation. Epilepsia. 44(s3). 33–40. 68 indexed citations
6.
Yerby, Mark S.. (2003). Corrections to: Clinical Care of Pregnant Women with Epilepsy: Neural Tube Defects and Folic Acid Supplementation. Epilepsia. 44(11). 1465–1465. 8 indexed citations
7.
Yerby, Mark S.. (2001). The use of anticonvulsants during pregnancy. Seminars in Perinatology. 25(3). 153–158. 18 indexed citations
8.
Yerby, Mark S.. (2000). Special Considerations for Women with Epilepsy. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 20(8P2). 159S–170S. 19 indexed citations
9.
Davis, Richard L., Antony E. Shrimpton, P D Holohan, et al.. (1999). Familial dementia caused by polymerization of mutant neuroserpin. Nature. 401(6751). 376–379. 283 indexed citations
10.
Davis, Richard L., P D Holohan, Antony E. Shrimpton, et al.. (1999). Familial Encephalopathy with Neuroserpin Inclusion Bodies. American Journal Of Pathology. 155(6). 1901–1913. 87 indexed citations
11.
Yerby, Mark S.. (1993). Epilepsy and Pregnancy: New Issues for an Old Disorder. Neurologic Clinics. 11(4). 777–786. 8 indexed citations
12.
Yerby, Mark S.. (1992). Risks of Pregnancy in Women with Epilepsy. Epilepsia. 33(s1). S23–6; discussion S26. 25 indexed citations
13.
Yerby, Mark S.. (1991). Pregnancy and Epilepsy. Epilepsia. 32(s6). S51–9. 71 indexed citations
14.
Yerby, Mark S., Patrick N. Friel, Karen Booth McCormick, et al.. (1990). Pharmacokinetics of anticonvulsants in pregnancy: Alterations in plasma protein binding. Epilepsy Research. 5(3). 223–228. 84 indexed citations
15.
Koerner, Michael M., et al.. (1989). Valproic Acid Disposition and Protein Binding in Pregnancy. Therapeutic Drug Monitoring. 11(3). 228–230. 16 indexed citations
16.
Yerby, Mark S., et al.. (1988). Complex Partial Seizures Associated with a Temporomandibular Joint Defect. Epilepsia. 29(3). 297–299. 3 indexed citations
17.
Yerby, Mark S.. (1988). Problems and Management of the Pregnant Woman with Epilepsy. Obstetrical & Gynecological Survey. 43(10). 602–603. 1 indexed citations
18.
Friel, Patrick N., Mark S. Yerby, & Karen Booth McCormick. (1987). Use of unbound drug concentrations to determine neonatal anticonvulsant exposure. Epilepsy Research. 1(1). 70–73. 7 indexed citations
19.
Yerby, Mark S.. (1987). Problems and Management of the Pregnant Woman with Epilepsy. Epilepsia. 28(s3). S29–36. 49 indexed citations
20.
Yerby, Mark S., et al.. (1986). Progressive dementia and epilepsy in a young adult. Neurology. 36(1). 68–68. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026